These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23798669)

  • 1. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
    Descamps D; Assoumou L; Chaix ML; Chaillon A; Pakianather S; de Rougemont A; Storto A; Dos Santos G; Krivine A; Delaugerre C; Montes B; Izopet J; Charpentier C; Wirden M; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Guinard J; Tamalet C; Cottalorda J; Marcelin AG; Desbois D; Henquell C; Calvez V; Brun-Vézinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2013 Nov; 68(11):2626-31. PubMed ID: 23798669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
    Frange P; Assoumou L; Descamps D; Chéret A; Goujard C; Tran L; Gousset M; Avettand-Fenoël V; Bocket L; Fafi-Kremer S; Guinard J; Morand-Joubert L; Nicot F; Plantier JC; Rogez S; Wirden M; Rouzioux C; Meyer L; Chaix ML; ;
    J Antimicrob Chemother; 2015 Jul; 70(7):2084-9. PubMed ID: 25885327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
    Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
    Assoumou L; Bocket L; Pallier C; Grude M; Ait-Namane R; Izopet J; Raymond S; Charpentier C; Visseaux B; Wirden M; Trabaud MA; Le Guillou-Guillemette H; Allaoui C; Henquell C; Krivine A; Dos Santos G; Delamare C; Bouvier-Alias M; Montes B; Ferre V; De Monte A; Signori-Schmuck A; Maillard A; Morand-Joubert L; Tumiotto C; Fafi-Kremer S; Amiel C; Barin F; Marque-Juillet S; Courdavault L; Vallet S; Beby-Defaux A; de Rougemont A; Fenaux H; Avettand-Fenoel V; Allardet-Servent A; Plantier JC; Peytavin G; Calvez V; Chaix ML; Descamps D;
    J Antimicrob Chemother; 2019 May; 74(5):1417-1424. PubMed ID: 30753724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
    Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
    de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
    Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
    Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
    J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.
    Oette M; Reuter S; Kaiser R; Lengauer T; Fätkenheuer G; Knechten H; Hower M; Pfister H; Häussinger D;
    Intervirology; 2012; 55(2):154-9. PubMed ID: 22286886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
    Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L;
    AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
    Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.
    Chaix ML; Descamps D; Wirden M; Bocket L; Delaugerre C; Tamalet C; Schneider V; Izopet J; Masquelier B; Rouzioux C; Meyer L; Costagliola D; ; ;
    AIDS; 2009 Mar; 23(6):717-24. PubMed ID: 19279445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
    Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
    J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
    Lambert-Niclot S; Charpentier C; Storto A; Fofana DB; Soulié C; Fourati S; Visseaux B; Wirden M; Morand-Joubert L; Masquelier B; Flandre P; Calvez V; Descamps D; Marcelin AG
    J Antimicrob Chemother; 2013 Jun; 68(6):1237-42. PubMed ID: 23361642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent transmission of HIV-1 drug-resistant variants.
    Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
    Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.